Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy
Tumor immunotherapy, as one of the most promising research directions in the present field of oncotherapy, inhibits and kills tumor cells by enhancing anti-tumor immunity of the body. PD-1/PD-L1 inhibitors block negative control signals by inhibiting binding of PD-1 to its ligand PD-L1, leading to r...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Third Party Medicine International Publishing Group Co. Limited
2017-06-01
|
| Series: | Journal of International Translational Medicine |
| Subjects: | |
| Online Access: | http://www.jitm.hk/EN/abstract/abstract245.shtml |